Combination of Conservative and Interventional Therapy Strategies for Intra- and Extrahepatic Cholangiocellular Carcinoma: A Retrospective Survival Analysis

Background. Due to the predominantly advanced stage at the time of diagnosis treatment of cholangiocarcinoma is difficult. Apart from surgical resection, interventional treatment strategies are increasingly used in advanced stage tumours. The aim of the study was a retrospective comparison of the effect of the various forms of treatment on morbidity and mortality. Method. A total of 195 patients, received either chemotherapy or a combination of photodynamic therapy (PDT) or transarterial chemoembolization (TACE) and chemotherapy. Results. The median survival rate for all patients was 15.6 months, 50.8% were still alive 1 year after diagnosis. Patients, who had previously undergone surgery, survived 17.1 months longer than those without surgical treatment (P < .01). Chemotherapy prolonged the survival by 9.2 months (P = .47). Palliative patients under combination of chemotherapy and PDT survived on average 1.8 months longer (P = .28), with chemotherapy and TACE 9.8 months longer (P = .04) compared to chemotherapy alone. Conclusions. It appears that surgical treatment and chemotherapy combined with PDT or TACE may prolong survival.

[1]  Natalia,et al.  Cholangiocarcinoma , 2010, Surgical Challenges in the Management of Liver Disease.

[2]  H. El‐Serag,et al.  Risk factors for cholangiocarcinoma , 2011, Hepatology.

[3]  F. Valvo,et al.  Cholangiocarcinoma: A position paper by the Italian Society of Gastroenterology (SIGE), the Italian Association of Hospital Gastroenterology (AIGO), the Italian Association of Medical Oncology (AIOM) and the Italian Association of Oncological Radiotherapy (AIRO). , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[4]  M. Kahaleh,et al.  Photodynamic therapy for cholangiocarcinoma. , 2010, Gut and liver.

[5]  R. Schmid,et al.  Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials , 2007, British Journal of Cancer.

[6]  T. Rösch,et al.  Therapieoptionen beim Hepatikusgabelkarzinom , 2007, Der Gastroenterologe.

[7]  D. Apel,et al.  Palliation of Nonresectable Bile Duct Cancer: Improved Survival After Photodynamic Therapy , 2005, The American Journal of Gastroenterology.

[8]  M. S. Lee,et al.  Prospective Study of the Effectiveness of Percutaneous Transhepatic Photodynamic Therapy for Advanced Bile Duct Cancer and the Role of Intraductal Ultrasonography in Response Assessment , 2005, Endoscopy.

[9]  M. Choti,et al.  Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. , 2005, Journal of vascular and interventional radiology : JVIR.

[10]  G. Gores,et al.  Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma , 2005, Journal of gastroenterology and hepatology.

[11]  M. Manns,et al.  Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver. , 2005, World journal of gastroenterology.

[12]  F. Berr,et al.  Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase II study. , 2004, Gastrointestinal endoscopy.

[13]  M. Ducreux,et al.  Biliary tract neoplasms: update 2003 , 2004, Current opinion in oncology.

[14]  M. Olnes,et al.  A Review and Update on Cholangiocarcinoma , 2004, Oncology.

[15]  Hannover,et al.  Cholangiozelluläres Karzinom und Gallenblasenkarzinom , 2004 .

[16]  M. Pandey,et al.  Carcinoma of the Gallbladder , 2001, Digestive Diseases and Sciences.

[17]  G. Gores.  A spotlight on cholangiocarcinoma. , 2003, Gastroenterology.

[18]  U. Mansmann,et al.  Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. , 2003, Gastroenterology.

[19]  T. Sauerbruch,et al.  Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma. , 2003, Gastrointestinal endoscopy.

[20]  H. Thomas,et al.  Changing international trends in mortality rates for liver, biliary and pancreatic tumours. , 2002, Journal of hepatology.

[21]  H. Thomas,et al.  Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document , 2002, Gut.

[22]  T. Takada,et al.  Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? , 2002, Cancer.

[23]  G. Gores,et al.  Endoscopic application of photodynamic therapy for cholangiocarcinoma. , 2000, Gastrointestinal endoscopy.

[24]  A. Tannapfel,et al.  Photodynamic therapy for advanced bile duct cancer: Evidence for improved palliation and extended survival , 2000, Hepatology.

[25]  A. Mironov,et al.  Risk factors of cholelithiasis relapse after lithotripsy and during prophilactic treatment with bile acids: Preliminary results of two-years follow-up study , 2000 .

[26]  H. Bismuth,et al.  Hepatobiliary surgery. , 2000, Journal of hepatology.

[27]  G. Minoli,et al.  Photodynamic therapy of nonresectable cholangiocarcinoma , 1999 .

[28]  T. Linné,et al.  Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  L. Påhlman,et al.  Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[30]  M. Makuuchi,et al.  Surgical treatment of intrahepatic cholangiocarcinoma: four patients surviving more than five years. , 1992, Surgery.

[31]  R. D. Barabash,et al.  Photodynamic therapy to treat tumors of the extrahepatic biliary ducts. A case report. , 1991, Archives of surgery.

[32]  T. Hwang,et al.  Clinical experience in 20 hepatic resections for peripheral cholangiocarcinoma , 1989, Cancer.

[33]  G. Klatskin.  CONGENITAL HEMOLYTIC JAUNDICE CORRECTED BY SPLENECTOMY FOLLOWED TWENTY-SIX YEARS LATER BY BLEEDING TENDENCY, HEPATOMEGALY AND SUDDEN DEATH. , 1965, The American journal of medicine.

[34]  G. Klatskin.  ADENOCARCINOMA OF THE HEPATIC DUCT AT ITS BIFURCATION WITHIN THE PORTA HEPATIS. AN UNUSUAL TUMOR WITH DISTINCTIVE CLINICAL AND PATHOLOGICAL FEATURES. , 1965, The American journal of medicine.